of f S Su up pe er ro ox xi id de e, , P Pe er ro ox xy yn ni it tr ri it te e a an nd d P Pr ro ot te ei in n K Ki in na as se e C C i in n t th he e C o p y r i g h t 2 0 0 3 b y t h e A m e r i c a n S o c i e t y f o r P h a r m a c o l o g y a n d E x p e r i m e n t a l T h e r a p e u t i c s . (Munzel et al., 1996; Parker and Parker, 1998) . Well established vascular mechanisms include desensitization of smooth muscle guanylate cyclase (Molina et al., 1987), enhanced cGMP breakdown due to increased phosphodiesterase activity (Pagani et al., 1993) and impaired GTN biotransformation (Slack et al., 1989). Humoral mechanisms include increases in plasma levels of catecholamines, vasopressin, angiotensin II and aldosterone, which elevate vascular resistance and blood volume (Stewart et al., 1986). Recently, it has been shown that GTN treatment of animals and cells increased the formation of superoxide (O 2 ⋅-) (Munzel et al., 1995; Dikalov et al., 1998; . Superoxide can be generated via multiple systems including xanthine oxidase, NADH/NADPH oxidase(s) and NO synthase (NOS). It rapidly reacts with and inactivates NO (Gryglewski et al., 1986) and produces peroxynitrite (ONOO -). L-arginine may also play a role in tolerance to organic nitrates in that reduced availability of L-arginine to NOS may occur from the direct inhibitory effects of NO, O 2 ⋅-and/or ONOO -, formed by GTN, on the transport of L-arginine into endothelial cells (Patel et al., 1996; Abou-Mohamed et al., 2000; Ogonowski et al., 2000) . In support of this, our previous experiments have demonstrated that supplementing L-arginine to rat aorta and humans partially prevents the development of tolerance to GTN (Abou-Mohamed et al., 2000; Parker et al., 2002) .
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Nitroglycerin (glyceryl trinitrate,GTN) is a vasodilator used in the therapy of cardiovascular diseases, such as angina pectoris, congestive heart failure and hypertension. However, use of GTN and other organic nitrates is limited by the development of nitrate tolerance, especially during continuous administration. Mechanisms of this tolerance have been extensively investigated and are thought to involve both vascular and humoral effects (Munzel et al., 1996; Parker and Parker, 1998) . Well established vascular mechanisms include desensitization of smooth muscle guanylate cyclase (Molina et al., 1987) , enhanced cGMP breakdown due to increased phosphodiesterase activity (Pagani et al., 1993) and impaired GTN biotransformation (Slack et al., 1989) . Humoral mechanisms include increases in plasma levels of catecholamines, vasopressin, angiotensin II and aldosterone, which elevate vascular resistance and blood volume (Stewart et al., 1986) . Recently, it has been shown that GTN treatment of animals and cells increased the formation of superoxide (O 2 ⋅-) (Munzel et al., 1995; Dikalov et al., 1998; . Superoxide can be generated via multiple systems including xanthine oxidase, NADH/NADPH oxidase(s) and NO synthase (NOS). It rapidly reacts with and inactivates NO (Gryglewski et al., 1986) and produces peroxynitrite (ONOO -). L-arginine may also play a role in tolerance to organic nitrates in that reduced availability of L-arginine to NOS may occur from the direct inhibitory effects of NO, O 2 ⋅-and/or ONOO -, formed by GTN, on the transport of L-arginine into endothelial cells (Patel et al., 1996; Abou-Mohamed et al., 2000; Ogonowski et al., 2000) . In support of this, our previous experiments have demonstrated that supplementing L-arginine to rat aorta and humans partially prevents the development of tolerance to GTN (Abou-Mohamed et al., 2000; Parker et al., 2002) .
A previous study has reported that a protein kinase C (PKC) inhibitor can prevent tolerance to GTN (Zierhut and Ball, 1996) . The PKC family includes at least 11 isozymes (Nishizuka, 1986) .
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Upon activation, PKC isozymes translocate from the cytoplasm to particulate structures where they are thought to mediate their catalytic functions (Kraft and Anderson, 1983) . Recent cardiovascular studies have revealed substantial "crosstalk" between the nitric oxide (NO) and PKC signaling pathways (Tazi et al., 2002; Liang and Knox, 1999; Li et al., 1998; Ping et al., 1999; Balafonova et al., 2002) . For example, treatment with NO donors triggers the translocation of the αPKC isozyme to the particulate fraction in kidney cells (Liang and Knox, 1999) . Nitric oxide has also been shown to directly stimulate PKC activities in heart tissue (Yoshida et al., 1999) . NO donors have been shown to activate the PKC signaling pathway via a mechanism involving production of ONOO -and tyrosine nitration of the εPKC isozyme (Balafanova et al., 2002) . This nitration enhances the interaction of εPKC with its intracellular receptor that targets εPKC to its active cell locus. In addition, O 2 ⋅-has been reported to be capable of activating PKC (Gopalakrishna and Anderson, 1989) ; (Knapp and Klann, 2000) . The activation and subsequent translocation of PKC trigger additional formation of O 2 ⋅- (Christiansen, 1988) . Thus, a "positive feedback" loop may result.
In the present study we have, therefore, investigated the interactive roles of GTN, reactive oxygen species (ROS) and PKC isozymes in the development of tolerance to GTN. Our work has therapeutic implications in the prevention of GTN tolerance and may be beneficial in the treatment of cardiovascular diseases.

METHODS
Vascular tone studies
In-vitro induction of tolerance. Male Sprague-Dawley rats (200-250 g) were lightly
anesthetized with ketamine and sacrificed. The descending thoracic aorta was removed, cleaned from the adjacent tissues and cut into ring segments of approximately 4 mm in length. Two metal hooks were passed carefully through the lumen of each ring and the tissues were then mounted under 2 x 10 -3 Newtons of tension in 25-ml organ baths containing Krebs solution. at 37°C and was continuously aerated with 5% CO 2 and 95% O 2 gas mixture. After equilibrium, a submaximal dose of phenylephrine, (PE, 3x10 -7 M -final, producing ~86% of maximum contraction) was added to the tissue bath and the full response allowed to develop. A concentration-response curve (CRC) for GTN was then constructed. The bathing solution was drained and replaced with fresh solution. The tissues were allowed to return to the baseline.
Tolerance to GTN was developed by incubating the tissues with 5 x 10 -4 M of GTN for 1 h followed by a replenishment of the same dose for a second hour.
In one series of experiments, 1) L-ascorbic acid (10 -3 M), a general anti-oxidant, 2) uric acid Krebs solution. In other experiments, only the actions of the anti-oxidants on the CEC to GTN were examined. Tissues were washed extensively every 15 min for 1 h post-incubation. Rings were reconstricted with PE and a second series of CRC for GTN were constructed.
In order to examine the effect of superoxide generation on GTN-induced relaxation, a second series of experiments were conducted. The tissues were contracted with PE and concentrationresponse curves were constructed. The rings were washed and exposed to a free radicalgenerating system of xanthine/xanthine oxidase (10 -5 M / 0.5 mU/ml). The treatment was replenished every 10 min for 1h. The aortic rings were washed 3 timed and cumulative dose response curves for GTN and sodium nitroprusside (SNP) were constructed. The pD 2 values for GTN (negative log of the dose producing 50% of the maximal response) were determined for each treatment. For each experiment, four ring segments were obtained from the rat and randomly assigned to one of our experimental treatments. All responses were expressed as a percentage of the response produced by a time control to PE alone.
In-vivo induction of tolerance. Male Sprague Dawley rats 200-250 g were utilized. Rats were anesthetized by an injection of mixture of xylazine and ketamine (40 mg/kg and 5 mg/kg, ip, respectively). The jugular vein was isolated and cannulated with a heparinized-saline filled PE-10 catheter. The catheters were advanced under the skin to the back of the neck and supported by a swivel and coiled wire conduit to the outside of the cage. The skin was sutured under aseptic condition. After complete recovery, animals were replaced in their cages. Three days later, rats were infused continuously with either saline or GTN at a dose of 15 mg/kg/day for three days with or without 4-hydroxy tempol (13.3 mg/kg/day) by means of syringe infusion pumps (Harvard). The development of tolerance was tested in vitro after 3 days of treatment as follows. Rats were sacrificed and their descending thoracic aortas were removed, and set up in tissue baths where concentration-response curves for GTN were constructed, as described above.
Cell Culture Experiments
Cell culture. Bovine aorta endothelial cells (BAEC) were obtained from Cell Systems (Kirkland, Washington) and maintained in medium-199 with 10% fetal bovine serum and penicillin and streptomycin through passages 4-7.
cGMP formation. BAEC were grown to ~90% confluency in 24 well plates and incubated in serum free and arginine deficient medium (M 199) for 2 hours. To determine the short term effects of GTN on cGMP levels, cells were further incubated with or without GTN (10 -6 M) for 10 mins in this M-199 medium containing IBMX (0.5 mM, Sigma). Following removal of medium, cell contents were harvested using 0.5 ml of 0.1N HCl and 0.1% Triton-X. To study the effects of tolerance inducing concentrations of GTN on cGMP level, cells were treated with GTN (10 -6 M) for 10 minutes before and after exposure to a tolerance inducing concentration of GTN (10 -5 M) for 1 hour. At the end of the treatments, cells were harvested as described above.
The cGMP levels were measured using enzyme-linked immunoassay commercial kit (ELISA kit, Assay Designs). The values are expressed as pmol/ml. Biotechnology). Oregon green-conjugated goat anti-rabbit antibody (Molecular Probes, Eugene, OR) was used to visualize the primary antibody. Data were analyzed using Ultra View morphometric program and fluorescence microscopy to quantify intensity of immunostaining.
Protein kinase C activation BAEC were incubated in serum-free and arginine deficient M199
for 2 hrs. Cells were then treated with 10 -5 M GTN for 0, 15, 30, 60, 120 and 180 min. One group of cells was treated with 10 nM PMA for 15 min as a positive control. At the end of treatment period, the media from one 100 mm dish of BAEC was removed and 0.5 ml of chilled homogenization buffer (10 mM Tris (hydroxymethyl -aminomethane), 1mM EDTA, 1mM
EGTA, 20 µg/ml of phenylmethysulfonylfluoride, soybean trypsin inhibitor, leupeptin, and aprotinin, pH 7.4 ) was added to each dish. The cells were scraped from the plates and triturated 3 times with a syringe and 22 gauge needle. The resulting lysates were centrifuged at 4° C for 20 min at 100,000 x g. The supernatants were concentrated using a Centricon 30 concentration device (Amicon Corporation, Beverly, MA) to a volume of 250 µl. The pellets were resuspended in 250 µl of homogenization buffer. Protein concentrations were measured by the Biorad micro protein assay (Biorad Laboratories, Hercules, CA) and samples equated for total protein were subjected to SDS-PAGE. Western blot analysis with PKC isozyme-selective antisera, 125 I-labeled protein A detection methods and autoradiography were conducted as previously described (Johnson and Mochly-Rosen, 1995; Johnson et al., 1996) . All antisera were from Transduction Laboratories and were used at 1:500 dilutions. Data were analyzed by densitometry (n = 2 to 3 samples).
Chemicals
All chemicals were made fresh on the day of use. Acetylcholine Cl, phenylepherine HC1, sodium nitroprusside, L-ascorbic acid, uric acid, 4-hydroxy tempol, chelerytherine, L-NAME, xanthine, and xanthine oxidase were purchased from Sigma-Aldrich Co (St. Louis, MO).
Xylazine and ketamine were purchased through our University's Animal Resources Division.
Nitroglycerin (SDM27) was a kind gift from Astra-Zeneca (Wilmington, DL).
Statistical Analysis
Data are presented as mean ± s.e. mean of the indicated number of observations (n) and the difference between groups was assessed using the paired t-test or analysis of variance, when appropriate. A probability value (P) less than 0.05 was considered to be statistically significant.
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RESULTS
Development of tolerance to GTN is associated with superoxide production in rat aorta. Nitroglycerin produced a concentration-dependent relaxation of constricted rat aortas with a pD 2 value of 8.83 ± 0.07. As shown in Figure 1 , incubation with a high concentration of GTN (5 x 10 -4 M) for 2 hours rendered the vessels less responsive to GTN. In these tolerant vessels, GTN produced a relaxation with a pD 2 value of 6.57 ± 0.2. Co-incubating vessels with the tolerance-inducing concentration of GTN along with the general anti-oxidant vitamin C (10 -3 M) significantly reduced tolerance development (pD 2 value of 8.18 ± 0.15) ( Figure 1A ). In a similar way, a peroxynitrite, peroxyl and OH˙ scavenging agent, uric acid (10 -3 M), significantly reduced tolerance development. The pD 2 value for GTN after uric acid was 7.8 ± 0.16 ( Figure 1B) . Moreover, the water-soluble SOD mimetic, 4-hydroxy tempol (10 -3 M), diminished the effect of a tolerance-inducing concentration of GTN. As a result, the pD 2 value for GTN was increased in the presence of 4-hydroxy tempol to 7.65 ± 0.16 as compared to 6.57 ± 0.2 in its absence ( Figure 1C ). Exposure of vessels to any of the three antioxidants without the tolerance-producing concentration of GTN did not alter or shift the concentration-response curves (CRC) to GTN ( Figure 2 ). These results implicate ROS species in the development of GTN tolerance in rat aortic rings.
The presence of chelerythrine (10 -6 M) during the tolerance producing exposure to GTN also reduced development of tolerance ( Figure 3A ). Co-incubating vessels with the tolerance-inducing concentration of GTN along with the general PKC inhibitor chelerythrine (10 -6 M) significantly reduced tolerance development. The pD 2 values for the CRC to GTN were 9.38 ± 0.14, 7.87 ± 0.09, and 9.24 ± 0.26, respectively, for control, GTN tolerant, and GTN plus chelerythrine. Concurrent incubation of vessels with chelerythrine (10 -6 M) and 4-hydroxy tempol (10 -3 M) along with GTN also reduced tolerance to a similar degree ( Figure 3B ). The pD 2 values for the CRC to GTN were 9.33 ± 0.21, 7.04 ± 0.12, and 8.25 ± 0.19, respectively, for control, GTN tolerant, and GTN plus chelerythrine and tempol.
In order to examine the role of superoxide in the production of tolerance to GTN, aortic rings were incubated with a xanthine/xanthine oxidase mixture and washed before a second CRC was constructed. As shown in Figure 4A , vessels exposed to superoxide were less sensitive to GTN than non-treated vessels as shown by 3.6-fold parallel shift in the CRC (pD 2 values are 7.20 and 7.76, respectively). In contrast, vasorelaxant responses to sodium nitroprusside (SNP) were not altered ( Fig.   4B ).
To further confirm the role of reactive oxygen species in in vivo development of tolerance to GTN, invivo tolerance was achieved by continuous i.v. infusion of GTN into rats for 3 days. Aorta were then tested in vitro. This treatment resulted in a 6.6 fold decrease in responsiveness to GTN in isolated aortic rings. When 4-hydroxy tempol was co-infused with GTN, it protected the rats against GTN tolerance. The pD 2 values for GTN on isolated rings were 8.63 ± 0.13, 7.81 ± 0.13 and 8.65 ± 0.16, from control rats treated with saline (control), GTN alone or GTN and 4-hydroxy tempol, respectively ( Figure 5 ). These results demonstrate that this antioxidant prevents tolerance to GTN administered in vivo.
Glyceryl trinitrate (GTN) induces tolerance to its ability to increase cGMP in endothelial cells.
Effects of GTN were also examined in endothelial cells. In BAEC not previously exposed to GTN, there was a marked increase in cGMP levels with a challenge dose of GTN (gtn, 10 but did not produce a rise in cGMP in response to the second challenge dose of GTN (gtn, 10 -6 M, 5 min). Thus, BAEC exhibit tolerance to GTN-induced cGMP responses.
Inhibiting NOS or scavenging superoxide blocks peroxynitrite formation.
Since concurrent elevation of NO and superoxide is associated with increased peroxynitrite levels, we investigated the effect of GTN on formations of peroxynitrite in BAEC (Figure 7 ). Peroxynitrite (ONOO -) is a short-lived molecule at physiologic pH, but it produces stable nitration of protein tyrosine residues. Thus, nitrotyrosine immunoreactivity can be used as an indicator for ONOO -formation. Our time course studies showed that GTN increases the ONOO -formation in BAEC in a time-dependent manner, reaching the maximum between 15 to 30 minutes ( Figure 7A insert).
Afterward, the levels of nitrotyrosine decreased gradually returning to basal levels after 180 minutes.
A sample photomicrograph illustrates cellular staining at + 30 min of GTN exposure ( Figure 7B ). Glyceryl trinitrate (GTN) induces sustained translocation of the α and εPKC isozymes to the particulate cell fraction in endothelial cells
The translocation of PKC isozymes from the cell supernatant to the cell particulate fraction has been used as an indirect measure of their activation in many cell types. We examined the effect of GTN on examples of three forms of isozymes of PKC -classical (α), novel (ε), and atypical (ζ). As a positive control for induction of PKC isozyme translocation, one group of BAEC was treated for 15 minutes with PMA (10 -8 M). PMA triggered a robust translocation of the α and εPKC isozymes but not the ζPKC isozyme to the particulate cell fraction (Figure 9 , lane 7).
Other groups of BAECs were treated with GTN (10 -5 M) for times ranging from 15 minutes to 1 hr and PKC isozyme translocation was monitored ( Figure 9 , lanes 2-6). A second GTN (10 -5 M) treatment was then administered at 60 minutes and PKC isozyme distribution was monitored for 2 additional hrs. Samples were taken at the times shown in the figure. Cells were then lysed, fractionated and subjected to Western blot analyses. As shown in the figure (lane 1), the αPKC isozyme was found predominantly in the cell supernatant (cytosolic) fraction prior to GTN treatment. Following a 15 min exposure to GTN, there was a complete redistribution of αPKC from the supernatant to the cell particulate fraction ( Figure 9 , lane 1 vs.2). However, by 30-60 min of GTN treatment αPKC immunoreactivity declined in the particulate fraction, but was still greater than in control, and reappeared in the cell supernatant fraction. Since GTN is rapidly metabolized, we hypothesized that the decline in αPKC translocation could be due to diminished GTN levels in our experiments. For that reason a second GTN bolus was delivered to the cells at 60 minutes which caused αPKC to once again repartition to the particulate cell fraction ( Figure   9 , lanes 5 and 6). The percentage of the αPKC isozyme found in the particulate cell fraction following 15 min., 1 hr and 3 hr GTN treatments were 100, 48 and 95%, respectively.
This article has not been copyedited and formatted. The final version may differ from this version. In contrast, the εPKC isozyme was found to be evenly distributed between the cell supernatant and particulate fractions prior to GTN treatment. Figure 9 demonstrates that GTN (10 -5 M) treatment stimulated the translocation of the supernatant-localized εPKC to the particulate fraction. Similar to our findings with the αPKC isozyme εPKC translocation attained a maximal level following 15 minutes of GTN exposure. However, εPKC remained in the particulate fraction longer than αPKC. There was a return of εPKC immunoreactivity to the supernatant fraction at 30-60 minutes of GTN exposure (lanes 3-4), but this effect was smaller in magnitude than was observed for the αPKC isozyme. A second treatment of BAECs with GTN (10 -5 M) triggered the retranslocation of the εPKC isozyme to the particulate fraction (lanes 5-6). Unlike the α and εPKC isozymes, the ζPKC isozyme was found almost entirely in the cell supernatant fraction before and after GTN treatments (Figure 9 , bottom). There was no significant redistribution of ζPKC in response to PMA or GTN in these cells. that GTN tolerance produced in rats by a 3 day i.v. infusion of GTN was also almost completely prevented by the concurrent infusion of tempol.
We also examined endothelial mechanisms that might contribute to tolerance to GTN. We first demonstrated that GTN induces tolerance to its ability to increase cGMP in cultured bovine This article has not been copyedited and formatted. The final version may differ from this version. aortic endothelial cells. Our data also showed that this effect is closely correlated with increases in tyrosine nitration of endothelial cell proteins and with translocation of the α and εPKC isozymes to the particulate fraction. Previous studies showing that tyrosine nitration of εPKC enhances its interaction with its intracellular receptor and movement to its active cell locus (Balafanova et al., 2002) suggest that these events are causally related. We next determined that the free radical scavengers SOD and uric acid completely abolished GTN-induced tyrosine nitration. These results indicate that GTN has marked oxidant effects on endothelial cells.
These results are in concert with our previous studies (Abou-Mohamed et al., 2000; . This endothelial dysfunction and tolerance to GTN may be mediated, at least in part, by ROS such as superoxide and peroxynitrite, tyrosine nitration, and the α and εPKC isozymes. Additionally, we found that the selective NOS inhibitor L-NAME also abolished tyrosine nitration of proteins in these cells implying that NOS activation is required for this effect. This result is consistent with our previous study showing a role for NOS activation in It is important to note that ONOO -has the prominent ability to oxidize tetrahydrobiopterin (BH4) to dihydrobiopterin (BH2) (Milstein and Katusic, 1999 Our observation that L-NAME blocked nitrotyrosine formation is consistent with our prior finding that eNOS is a site of superoxide formation in endothelial cells treated with GTN .
Antioxidants protect y + transport function (Patel et al., 1996) and thereby provide arginine to the site of eNOS activity and interrupt this cycle. The y + system transporter also has recently been reported to be regulated by PKCα in porcine pulmonary artery endothelial cells (Krotova et al., 2003) . With activation of PKCα, an initial suppression ( < 1 hr) and a secondary increase (4-18 hr) in L-arginine transport were observed. These investigators suggest that translocated PKCα may inhibit L-arginine uptake by phosphorylation of the transporter. However, our data suggest that enhancement of O 2˙-and ONOO -production by PKC and GTN may oxidize the transporter and inhibit its function.
This article has not been copyedited and formatted. The final version may differ from this version. (Munzel et al., 2000) have shown that three day treatment of rats with GTN enhanced eNOS (type III) expression and O 2˙-production from eNOS. Furthermore, treatment of aortic rings with PKC inhibitors reduced O 2˙-production and tolerance to GTN. Our previous study also demonstrated the depressive action of GTN on L-arginine uptake in endothelial cells (AbouMohamed et al., 2000) . In our present study, we also have noted that an increase endothelial cell production of cGMP in response to GTN is absent after sustained exposure to GTN (10 -5 M for 1 hr). Thus, endothelial cells do exhibit a tolerance to an action of GTN.
A recent report using eNOS knockout and wild-type mice has suggested that endothelial NOS may not be critically involved in GTN tolerance because the degrees of tolerance to GTN in these two mouse strains were similar (Wang et al., 2002) . We do not believe that this is the case because others have shown that in eNOS knock-out mice, expression of neural (n, type I) NOS is from NAPDH oxidase subsequently further inactivating system y + uptake of arginine and leading to reduced arginine levels at the site of eNOS activity and more superoxide as the end result.
Inhibitors of PKC, as well as antioxidants and L-arginine, would be expected to ameliorate tolerance to GTN by interrupting this vicious cycle. A proposed scheme of events is given in Figure 10 .
In summary, tolerance to GTN in humans limits its therapeutic capacity as its effects wane with continuous use. The molecular mechanisms contributing to this tolerance has been studied extensively in vascular smooth muscle but the contribution of vascular endothelial cells to this phenomenon has received less attention. We therefore, have investigated this aspect of GTNinduced tolerance in intact rat aorta preparations and in isolated bovine aortic endothelial cells in culture. Our results indicate that GTN tolerance occurs at the level of endothelial cells and is associated with: 1) activation of NOS and PKC, and 2) production of superoxide and peroxynitrite free radicals, which occur temporally with the activation of the α and εPKC isozymes. These findings suggest potential therapeutic roles for agents which reduce ROS levels and selective inhibitors of PKC isozymes in attenuating nitrate tolerance.
This article has not been copyedited and formatted. The final version may differ from this version. isolated from these rats (▲). These GTN concentration-response curves were compared to those obtained using vessel segments from rats treated with a 3 day i.v. infusion of 4-hydroxy tempol (13.3 mg/kg/day) in addition to GTN infusion (dashed line ■ ), and vessels from control rats, not receiving infusion of either agent (◊). Values are pmol/ml/5 min (*P<0.05 vs control levels). 
